What is he best known for?
The fields of study he is best known for:
Virology, Immunology, Immunity, Vaccinia and Vaccination are his primary areas of study.
His Virology study incorporates themes from Viral vector and CD8, Immune system, Antigen.
His research links Heterologous with Immunology.
The concepts of his Immunity study are interwoven with issues in Plasmodium falciparum and Antibody.
The various areas that Stefano Colloca examines in his Vaccinia study include Virus and Immunization.
His work carried out in the field of Vaccination brings together such families of science as Vector and Immunogenicity.
His most cited work include:
- Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man (322 citations)
- A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees. (272 citations)
- Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge (254 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Virology, Immunology, Antigen, Vaccination and Viral vector.
His Virology research incorporates elements of T cell, Immune system, Immunity and Immunogenicity.
His studies deal with areas such as Vaccinia and Modified vaccinia Ankara as well as Immunology.
Stefano Colloca combines subjects such as Plasmodium falciparum, Heterologous and Cancer research with his study of Antigen.
His Vaccination research is multidisciplinary, incorporating perspectives in Ebola vaccine, Neutralizing antibody and Ebolavirus.
His study looks at the relationship between Viral vector and fields such as Adenoviridae, as well as how they intersect with chemical problems.
He most often published in these fields:
- Virology (84.44%)
- Immunology (48.89%)
- Antigen (36.67%)
What were the highlights of his more recent work (between 2015-2021)?
- Virology (84.44%)
- Vaccination (32.22%)
- Antigen (36.67%)
In recent papers he was focusing on the following fields of study:
Stefano Colloca mainly investigates Virology, Vaccination, Antigen, T cell and Immunology.
Stefano Colloca has researched Virology in several fields, including Immune system, Immunity, Immunogenicity, Viral vector and Epitope.
His Immunogenicity research incorporates themes from Vector and Modified vaccinia Ankara.
His study in the fields of Chimpanzee adenovirus under the domain of Viral vector overlaps with other disciplines such as Laminin.
His studies examine the connections between Vaccination and genetics, as well as such issues in Simian, with regards to Anti viral immunity and Clinical trial.
Stefano Colloca interconnects Virus, Cancer research and Antibody in the investigation of issues within Antigen.
Between 2015 and 2021, his most popular works were:
- A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA (250 citations)
- Chimpanzee Adenovirus Vector Ebola Vaccine (168 citations)
- A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH (57 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Virology, Immunology, Immunity, Vaccination and Immunogenicity.
His Virology research is multidisciplinary, relying on both ELISPOT, Mucosal immunity and Immune system.
His Mucosal immunity research incorporates elements of Viral vector and Chimpanzee adenovirus.
His studies deal with areas such as Viremia, Antigen and Modified vaccinia Ankara as well as Viral load.
His Antigen study combines topics in areas such as Interferon and Hepatitis C virus.
His Ebola virus research includes elements of Vaccinia and Antibody.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
